BioCentury | Mar 28, 2011
Clinical News

ColoVantage regulatory update

...The New York State Department of Health approved Quest's blood-based ColoVantage colorectal cancer diagnostic. New York...
...a 2008 deal (see BioCentury, Feb. 25, 2008). Quest Diagnostics Inc. (NYSE:DGX), Madison, N.J. Product: ColoVantage...
BioCentury | Jan 18, 2010
Company News

Quest Diagnostics sales and marketing update

...Quest launched its blood-based ColoVantage colorectal cancer diagnostic in the U.S. The test is based on...
Items per page:
1 - 2 of 2